DexCom Inc.

Dexcom, Inc. (NASDAQ: DXCM) is a leading medical technology company revolutionizing diabetes care with its innovative continuous glucose monitoring (CGM) systems. Founded in 1999 and headquartered in San Diego, California, Dexcom has established a dominant position in the growing CGM market with flagship products like the G6 and G7 systems. These devices offer real-time glucose data, reducing complications and enhancing quality of life for users. The company’s strong financial performance is driven by increasing global demand, supported by expanded manufacturing operations in the U.S., Malaysia, and Ireland. Dexcom's strategic focus on R&D, product innovation, and international market penetration positions it for sustained growth in the diabetes technology sector.